CONDENSED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses:
Research and development	$ 7,769	$ 2,107	$ 18,040	$ 7,969
General and administrative	1,790	457	3,041	2,004
Total operating expenses	9,559	2,564	21,081	9,973
Loss from operations	(9,559)	(2,564)	(21,081)	(9,973)
Interest expense	(79)	(5)	(245)	(5)
Other income, net	51	18	125	72
Net loss	$ (9,587)	$ (2,551)	$ (21,201)	$ (9,906)
Net loss per share, basic and diluted	$ (12.35)	$ (3.34)	$ (27.54)	$ (12.96)
Weighted-average shares of common stock outstanding, basic and diluted	776,159	764,408	769,766	764,408